However, the optimal regime of octreotide remains controversial, partly due to the ignorance of monitoring the real-time plasma levels of SST and crucial pro-inflammatory cytokines, along with the progression of AP. Therefore, to explore find more the superior dosage and duration, real-time testing of plasma SST, tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) levels during different octreotide therapies, and analysis of the association between
these and the clinical outcomes are valuable. Methods: Sixty patients with predicted severe acute pancreatitis (P-SAP) were randomized into two groups. P-SAP-1 group received intravenous infusion of octreotide at 50 μg/h × 3 d + 25 μg/h × 4 d.
P-SAP-2 group received the same regime followed by 0.1 mg hypodermic injection q 8 h × 3 d. The blood sample were collected on day 0, day 1–3, day 4, day 5–7, day 8–10 and day 11–20. Results: The decreased plasma SST level recovered efficiently in P-SAP on day1–3 (vs. day 0 p < 0.001), decreased dramatically on day 4 (vs. day 0 p = 0.101), and then recovered on day 5–7 (vs. day 0 p = 0.017). Furthermore, SST decreased on day 8–10 again and recovered on day 11–20 (vs. day 0 p = 0.001) in P-SAP-1. On day 8–10 and 11–20 in P-SAP-2, SST stayed normal. Additionally, the plasma levels of IL-6 and TNF-α decreased on day 1–3 (p < 0.001) and maintained Rapamycin price low levels in the subsequent days in both groups. Occurrences of SAP and local complications selleck inhibitor in P-SAP-2 were significantly lower than those
in P-SAP-1 (p < 0.001). Conclusion: On the base of intravenous injection, extra subcutaneous octreotide injection could ameliorate the plasma SST level and reduce cytokines, and occurrences of SAP and local complications. Key Word(s): 1. acute pancreatitis; 2. octreotide; 3. somatostatin; 4. cytokines; Presenting Author: SHIQI WANG Additional Authors: XUJIE ZHANG, SHUJUN LI, QUANXIN FENG, XIANGYING FENG, QINGCHUAN ZHAO Corresponding Author: QUANXIN FENG, QINGCHUAN ZHAO Affiliations: Xijing Hospital of Digestive Diseases, Fourth Military Medical University Objective: Few risk factors which predict the occurrence of severe acute pancreatitis (SAP) have been identified. Theoretically, fatty liver may contribute to increased inflammation during the course of AP and can therefore be considered a risk factor for SAP. However, fatty liver is a common comorbidity of obesity, which by itself is a definite risk factor of SAP. Thus, this study was performed to investigate the role of fatty liver in the process of acute pancreatitis (AP). Methods: This is a retrospective cohort study.